Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Nom du journal : Lancet Healthy Longev
Année : 2024
Volume : 5
Page de départ : e392-e405
